|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.182
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.182
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.130
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.105
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.105
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.100
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.093
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.088
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.086
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.083
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.083
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.081
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.081
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.080
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.079
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.075
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.075
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.074
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.072
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.070
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.070
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.069
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.067
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.067
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.066
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.064
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.063
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.062
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.061
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.061
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.060
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.058
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.058
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.057
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.057
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.057
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.056
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.055
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.054
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.054
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.054
|
|
|
|
regulation of satellite cell activation involved in skeletal muscle regeneration
|
GO:0014717 |
3 |
0.053
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.053
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.052
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.051
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.051
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.049
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.049
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.048
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.048
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.048
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.047
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.047
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.046
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.046
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.046
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.046
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.046
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.046
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.045
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.045
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.044
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.044
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.044
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.044
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.043
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.043
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.042
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.042
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.042
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.042
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.042
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.041
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.041
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.041
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.041
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.041
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.041
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.040
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.040
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.040
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.040
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.040
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.039
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.039
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.039
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.039
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.038
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.038
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.038
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.038
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.037
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.037
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.037
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.037
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.037
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.037
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.037
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.037
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.037
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.036
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.036
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.035
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.035
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.035
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.035
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.035
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.035
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.035
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.035
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.034
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.034
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.034
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.033
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.033
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.033
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.033
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.033
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.033
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.032
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.032
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.032
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.032
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.032
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.031
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
regulation of circadian sleep wake cycle
|
GO:0042749 |
3 |
0.031
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.031
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.031
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.031
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.031
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.030
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.030
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.030
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.030
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.030
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.029
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.029
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.029
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.029
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.029
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.029
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.028
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.028
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.028
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.028
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.028
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.028
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.028
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.028
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.028
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.028
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.028
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.028
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.027
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.027
|
|
|
|
interleukin 10 secretion
|
GO:0072608 |
4 |
0.027
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.027
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.027
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.027
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.026
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.026
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.026
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.026
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.026
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.026
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.026
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.025
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.025
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.025
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.025
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.025
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.025
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.025
|
|
|
|
positive regulation of transforming growth factor beta secretion
|
GO:2001203 |
1 |
0.024
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.024
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.024
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.024
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.024
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.024
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.024
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.024
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.024
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.024
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.024
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.024
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.024
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.023
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.023
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.023
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.023
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.023
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.023
|
|
|
|
homophilic cell adhesion via plasma membrane adhesion molecules
|
GO:0007156 |
18 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.022
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.022
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.022
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.022
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.022
|
|
|
|
leukocyte degranulation
|
GO:0043299 |
27 |
0.021
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.021
|
|
|
|
regulation of transforming growth factor beta secretion
|
GO:2001201 |
1 |
0.021
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.021
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.021
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.021
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
62 |
0.021
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.021
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.021
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.021
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.021
|
|
|
|
regulation of circadian sleep wake cycle sleep
|
GO:0045187 |
3 |
0.021
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.020
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.020
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.020
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.020
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.020
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.020
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.020
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.020
|
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.020
|
|
|
|
oligopeptide transmembrane transport
|
GO:0035672 |
4 |
0.020
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.020
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.020
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.020
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.020
|
|
|
|
myeloid leukocyte mediated immunity
|
GO:0002444 |
42 |
0.020
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.020
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.020
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.020
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.020
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.020
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.020
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.020
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.019
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.019
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.019
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.019
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.019
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.018
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.018
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.018
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.018
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.018
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.018
|
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.018
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.018
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.018
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.018
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.018
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.018
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.018
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
negative regulation of feeding behavior
|
GO:2000252 |
1 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.018
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.017
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.017
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.017
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.017
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.017
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.017
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.017
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.017
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.017
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.017
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.017
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.017
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.017
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.017
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.017
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
|
positive regulation of skeletal muscle tissue regeneration
|
GO:0043415 |
4 |
0.017
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.017
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.017
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.017
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.017
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.017
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.017
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.017
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.017
|
|
|
|
innate immune response activating cell surface receptor signaling pathway
|
GO:0002220 |
4 |
0.017
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.017
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.017
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.017
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.017
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.017
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.016
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.016
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.016
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.016
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.016
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.016
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.016
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.016
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.016
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.016
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.016
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.016
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.016
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.016
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.016
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.016
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.016
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.016
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.016
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.016
|
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.016
|
|
|
|
myeloid cell activation involved in immune response
|
GO:0002275 |
34 |
0.016
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.015
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.015
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.015
|
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.015
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.015
|
|
|
|
regulation of mast cell activation involved in immune response
|
GO:0033006 |
17 |
0.015
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.015
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.015
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.015
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.015
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.015
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.015
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.015
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.015
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.015
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.015
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.015
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.015
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.015
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.015
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.015
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.015
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.015
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.015
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.015
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.014
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.014
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.014
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.014
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.014
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.014
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.014
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.014
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.014
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.014
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.014
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.014
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.014
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.014
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.014
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.014
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.014
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.014
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.014
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.013
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.013
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.013
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.013
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.013
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.013
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.013
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.013
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.013
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.013
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.013
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.013
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.013
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.013
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.013
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.013
|
|
|
|
regulation of chloride transport
|
GO:2001225 |
2 |
0.013
|
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
2 |
0.013
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.013
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.013
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.013
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.013
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.013
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.013
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.013
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.013
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.013
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.013
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.012
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.012
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.012
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.012
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.012
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.012
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.012
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.012
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.012
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.012
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.012
|
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.012
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.012
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.012
|
|
